[1]
2018. Monitoring the Effects of Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Switch for Tubulotoxicity in Highly Treatment-Experienced or in Very Sick Individuals Infected with HIV. Journal of Renal and Hepatic Disorders. 2, 2 (Jun. 2018), 1–5. DOI:https://doi.org/10.15586/jrenhep.2018.33.